Medical Microbiology And Immunology

杂志介绍

Medical Microbiology And Immunology杂志介绍

《Medical Microbiology And Immunology》是一本以English为主的未开放获取国际优秀期刊，中文名称医学微生物学和免疫学，本刊主要出版、报道医学-免疫学领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.961，最新CiteScore 指数为9.5。

本刊近期中国学者发表的论文主要有：

• High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in Chin

  Author:

• Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvan

  Author:

• <Emphasis Type="Italic">Legionella feeleii</Emphasis>: pneumonia or Pontiac fever? Bacterial virulence traits and host immune respons

  Author:

• The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replicatio

  Author:

英文介绍

Medical Microbiology And Immunology杂志英文介绍

Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal´s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens.

MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question.

The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention.

The following categories of manuscripts will not be considered for publication in MMIM:

submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest,

manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs,

manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action,

manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem,

case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.